Viewing Study NCT01013506

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 5:23 PM

Ignite Modification Date: 2025-12-29 @ 12:46 AM

Study NCT ID: NCT01013506

Status: WITHDRAWN

Last Update Posted: 2013-05-23

First Post: 2009-11-12

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer

Sponsor: Vanderbilt-Ingram Cancer Center

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module